A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics of DZD8586 in Healthy Adult Participants
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
This is a study in healthy adult participants. This is the first time this drug has ever been
tested in human, and so it will help to understand what type of side effects may occur with
this intervention. It will also measure the levels of drug in the body.